Mona Meyer
Mona Meyer
Hospital for Sick Children, Toronto, Canada
Verified email at sickkids.ca
Title
Cited by
Cited by
Year
Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and EnrichmentMap
J Reimand, R Isserlin, V Voisin, M Kucera, C Tannus-Lopes, ...
Nature protocols 14 (2), 482-517, 2019
4802019
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
M Meyer, J Reimand, X Lan, R Head, X Zhu, M Kushida, J Bayani, ...
Proceedings of the National Academy of Sciences 112 (3), 851-856, 2015
2992015
Impact of outdated gene annotations on pathway enrichment analysis
L Wadi, M Meyer, J Weiser, LD Stein, J Reimand
Nature methods 13 (9), 705-706, 2016
982016
Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy
M Meyer, D Rübsamen, R Slany, T Illmer, K Stabla, P Roth, T Stiewe, ...
PLoS One 4 (11), e7768, 2009
292009
Solitary fibrous tumors of the pleura
M Meyer, U Krause
Der Chirurg; Zeitschrift fur Alle Gebiete der Operativen Medizen 70 (8), 949-952, 1999
181999
Grafik-Ausgabe vom Parallelrechner für 2D-Gebiete
M Pester
91994
Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
RK Goel, M Meyer, M Paczkowska, J Reimand, F Vizeacoumar, ...
Proteome science 16 (1), 1-14, 2018
82018
Impact of knowledge accumulation on pathway enrichment analysis
L Wadi, M Meyer, J Weiser, LD Stein, J Reimand
bioRxiv, 049288, 2016
72016
Gra k-Ausgabe vom Parallelrechner f ur 3D-Gebiete
M Meyer
Preprint SPC 95 (4), 1995
71995
Chromatin blueprint of glioblastoma stem cells reveals common drug candidates for distinct subtypes
P Guilhamon, MM Kushida, G MacLeod, SAM Tonekaboni, FMG Cavalli, ...
bioRxiv, 370726, 2018
32018
Proton beams for physics experiments at oncoray
S Helmbrecht, F Fiedler, M Meyer, P Kaever, T Kormoll
Radiotherapy and Oncology 118, S60-S61, 2016
32016
Single Cell Derived Clonal Analysis of Human Glioblastoma Links Functional and Genomic Heterogeneity
PB Dirks, M Meyer, J Reimand, X Lan, R Head, X Zhu, M Kushida, ...
Neuro-oncology 16 (Suppl 3), iii14, 2014
32014
OS2. 7 An open-labelled, randomized phase II study in patients with recurrent Glioblastoma Multiforme comparing progression free survival of ALECSAT (Autologous lymphoid …
C Haslund, A Muhic, S Lukacova, B Lund, Y Lassen-Ramshad, M Meyer, ...
Neuro-Oncology 18 (suppl_4), iv6-iv6, 2016
22016
Synthesis of 14C-Labeled and Unlabeled Humic Acid Type M42
S Pompe, M Bubner, M Meyer, R Nicolai, KH Heise, G Bernhard
Annual Report 2000 Institute of Radiochemistry, 31, 2001
22001
Solitäre fibröse Pleuratumoren
M Meyer, U Krause
Der Chirurg 70 (8), 949-952, 1999
21999
Publications Repository-Helmholtz-Zentrum Dresden-Rossendorf
C Salazar-Mejia, V Kumar, C Felser, Y Skourski, J Wosnitza, AK Nayak
Physical Review Applied Phys Rev Applied 11, 054006, 2019
2019
Cell Surface Profiling Using High-Throughput Flow Cytometry: A Platform for Biomarker Discovery and Analysis of Cellular Heterogeneity (vol 9, e105602, 2014)
M Meyer
PLOS ONE 9 (11), 2014
2014
Abstract B29: Defining subclonal signaling heterogeneity in glioblastoma multiforme (GBM)
X Lan, M Meyer, J Reimand, X Zhu, M Kushida, R Head, I Clarke, G Bader, ...
Cancer Research 73 (19 Supplement), B29-B29, 2013
2013
Oncogenic RAS Enables DNA Damage-and p53-Dependent Differentiation of Acute
M Meyer, D Rübsamen, R Slany, T Illmer, K Stabla
2009
Ras-induzierte Differenzierung nach Schädigung der DNA in Zellen der akuten myeloischen Leukämie
M Meyer
2009
The system can't perform the operation now. Try again later.
Articles 1–20